Bassam R. Ali - Publications, H-index & Citations

Bassam R. Ali

department of genetics and genomics

42H指数

246论文数

6.1K被引数

收录论文 92

发表时间

Receptor tyrosine kinase families: a central hub of cellular signaling and involvement in human health and disease 受体酪氨酸激酶家族：细胞信号传导的中心枢纽，并参与人类健康与疾病

Human Genomics

IF4.3

2026-09-14

OAAI

Anjana Raj; Fadia Abu-Sailik; Aseel A. Jawabri; Batool M. Ahmad; Feda E. Mohamed; Bassam R. Ali

Clinically interpretable deep learning for breast cancer missense variant pathogenicity prediction 临床可解释的深度学习用于乳腺癌错义变异致病性预测

Frontiers in Bioinformatics

IF3.9

2026-07-23

OAAI

RM Rahaf M. Ahmad †; NA Noura AlDhaheri †; MS Mohd Saberi Mohamad †; BR Bassam R. Ali †

ExposoGenomics: integrating genome and exposome as jointly dynamic systems for causal discovery and precision health ExposoGenomics：将基因组与暴露组整合为联合动态系统，用于因果发现和精准健康

Human Genomics

IF4.3

2026-07-21

OAAI

Vasilis Vasiliou; Nicholas Katsanis; Giuseppe Novelli; Juergen K. V. Reichardt; Bassam R. Ali; Maria Gazouli; Sek Won Kong; Hongyu Zhao; Kiril Veselkov; Bhramar Mukherjee; Dimosthenis Sarigiannis

Comparative cytotoxicity and genotoxicity of commercial glyphosate-based herbicide formulations and co-formulants in human leukocyte and hepatocyte cell lines 商业草甘膦基除草剂配方及其助剂在人类白细胞和肝细胞系中的比较细胞毒性和遗传毒性

Frontiers in Toxicology

IF4.6

2026-07-15

OAAI

MS Moustafa Sherif; AN Abderrahim Nemmar; BR Bassam R. Ali; KM Khadija Makame; KN Károly Nagy; BÁ Balázs Ádám

AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework 人工智能基因组学协同用于乳腺癌药物重定位：一种可解释性驱动的框架

npj Genomic Medicine

IF4.8

2026-05-20

OAAI

Rahaf M. Ahmad; Salahdein Aburuz; Bassam R. Ali; Noura AlDhaheri

Correction: Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors 修正：组合疗法策略以克服免疫检查点抑制剂耐药性

Frontiers in Immunology

IF5.9

2026-04-27

OAAI

BH Besan H. Alsaafeen †; BR Bassam R. Ali †; EE Eyad Elkord †

Moderate-intensity statin plus ezetimibe as an alternative to high-intensity statin therapy 中等强度他汀联合依折麦布作为高强度他汀疗法的一种替代方案

Cardiovascular Diabetology

IF10.6

2026-04-25

OAAI

Areej S. Albawa’neh; Bassam R. Ali

HMGCR genetic variation and risk of new-onset type 2 diabetes in statin users HMGCR基因变异与他汀使用者中新发2型糖尿病的风险

Human Genomics

IF4.3

2026-04-11

OAAI

Areej S. Albawa’neh; Mais N. Alqasrawi; Zeina N. Al-Mahayri; Nour al dain Marzouka; Lilas Dabaghie; Dana Hamza; Lubna Q. Khasawneh; Virendra Misra; Husam Ouda; Bassam R. Ali

Combined Role of CYP3A4 and CYP3A5 genetic variants in tacrolimus dose-adjusted trough levels: a clinical retrospective study in kidney transplant patients CYP3A4和CYP3A5基因变异在他克莫司剂量调整谷浓度中的联合作用：一项在肾移植患者中的临床回顾性研究

The Pharmacogenomics Journal

IF0

2026-01-06

PREAI

Anna Tsironi; Effrosyni Mendrinou; Stavroula Siamoglou; Kyriaki Kydonopoulou; Anne John; Alexandra Gerou; Spyridon Gerou; Bassam R. Ali; Marios Papasotiriou; George P. Patrinos

Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis 依折麦布与新发2型糖尿病风险：一项系统评价和Meta分析

ANNALS OF MEDICINE

IF4.3

2025-12-31

PREAI

Albawa'neh, Areej S.; Alqasrawi, Mais N.; Al-Mahayri, Zeina N.; Albawaana, Amal; Ahmed, Gamila; Al-Rifai, Rami H.; Ali, Bassam R.

Strategic insights into pharmacogenomics coverage: a theory-informed SWOT analysis of UAE insurance stakeholders’ perspectives

Human Genomics

IF4.3

2025-12-29

OAAI

Maram O. Abbas; Azhar T. Rahma; Iffat Elbarazi; Bassam R. Ali; George P. Patrinos; Hana Ghadibah; Fatma Al-Maskari

Comparative analysis of point-of-care bedside cyp2c19-testing guided anti-platelet therapy versus conventional therapies for cardiovascular diseases: a systematic review and meta-analysis 心血管疾病中，基于床旁CYP2C19检测指导的抗血小板疗法与传统疗法的比较分析：一项系统评价和荟萃分析

The Pharmacogenomics Journal

IF0

2025-11-12

PREAI

Mohammed Khattab; Mohamed Baguneid; George P. Patrinos; Bassam R. Ali; Salahdein Aburuz

A diagnostic RNA sequencing assay for direct identification and interpretation of pathogenic variants in the FBN1 gene 一种用于直接识别和解释FBN1基因致病变异的诊断RNA测序检测方法

Frontiers in Molecular Biosciences

IF4

2025-11-03

OAAI

Manal Irshaid; Ghadeera Al Mansoori; Mohamed Sulaiman; Asjed Mohamed; Mohammed Abdoh; Youssef M. Shalaby; Bashar Al-Zohily; Aalia Batool; Sara Aleissaee; Lara Alzyoud; Bassam R. Ali; Muna Al Saffar; Nadia Akawi

Precision in prediction: tailoring machine learning models for breast cancer missense variants pathogenicity prediction 预测精度：针对乳腺癌错义变异致病性预测定制机器学习模型

BRIEFINGS IN BIOINFORMATICS

IF7.7

2025-11-01

PREAI

Ahmad, Rahaf M.; AlDhaheri, Noura; Mohamad, Mohd Saberi; Ali, Bassam R.

Leveraging AutoML to Optimize Dataset Selection for Improved Breast Cancer Variant Pathogenicity Prediction 利用AutoML优化数据集选择，以提高乳腺癌变异致病性预测

Computational and Structural Biotechnology Journal

IF4.1

2025-10-27

OAAI

Rahaf M. Ahmad; Noura Al Dhaheri; Mohd Saberi Mohamad; Bassam R. Ali

Evaluation of the functional impact of rare CYP2C19 missense variants identified in understudied Populations: An Integrated in silico and in vitro analysis 评估在研究不足人群中鉴定出的罕见CYP2C19错义变异的功能影响：一项整合的计算机模拟和体外分析

Biochemical Pharmacology

IF5.6

2025-09-20

PREAI

Reema Saleous; Eiji Hishinuma; Zeina N. Al-Mahayri; Akiko Ueda; Yuma Suzuki; Mohammad A. Ghattas; Radwa E. Mahgoub; Masahiro Hiratsuka; Bassam R. Ali

A multi-centre observational cohort study on pharmacogenomic predictors of rosuvastatin discontinuation in a multiethnic population 一项关于多民族人群中罗苏伐他汀停药药基因组学预测因子的多中心观察性队列研究

Frontiers in Pharmacology

IF4.8

2025-08-29

OAAI

Mais N. Alqasrawi; Zeina N. Al-Mahayri; Lubna Q. Khasawneh; Areej S. AlBawa’neh; Lilas Dabaghie; Sahar M. Altoum; Dana Hamza; Salahdein Aburuz; Virendra Misra; Gohar Jamil; Husam Ouda; Faiz Al-Bakshy; Khuzama AlAhamad; Mohammad M. Al-Ahmad; Fatima Al-Maskari; Juma AlKaabi; George P. Patrinos; Bassam R. Ali†

Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates 心血管疾病患者对阿联酋药物基因组学的认知与观点

cts clinical and translational science

IF0

2025-08-11

OAAI

Maram O. Abbas; Azhar T. Rahma; Iffat Elbarazi; Bassam R. Ali; George P. Patrinos; Farah Nagy; Alya Osman; Reem K. Alneyadi; Anwar S. Alshamsi; Mohamed Alraqabani; Zeina Al-Mahayri; Fatma Al-Maskari

Hartnup disease-causing SLC6A19 mutations lead to B0AT1 aberrant trafficking and ACE2 mis-localisation implicating the endoplasmic reticulum protein quality control Hartnup疾病致病性SLC6A19突变导致B0AT1异常转运和ACE2错位，涉及内质网蛋白质质量控制。

Frontiers in Cell and Developmental Biology

IF4.3

2025-08-07

OAAI

Nesreen F. Alkhofash; Bassam R. Ali†

Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors 组合疗法策略以克服对免疫检查点抑制剂的耐药性

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-04-24

OAAI

Alsaafeen, Besan H.; Ali, Bassam R.; Elkord, Eyad

研究方向